Key information summary
Efficacy & effects
This medication is used to reversibly alleviate respiratory depression caused by opioid drugs, such as natural and synthetic narcotics, proproxyphene, and methadone. It is also utilized for accurate diagnosis in acute situations where drug overdose is suspected. This effect helps restore respiratory function and rapidly improve symptoms of acute intoxication. Therefore, this medication is effectively used in emergencies caused by opioid overdose.
Dosage
Naloxone hydrochloride is administered intravenously, intramuscularly, or subcutaneously. The fastest onset occurs after intravenous administration, which is recommended in emergencies. 1) In cases of suspected opioid overdose or overdose (1) The initial intravenous dose of naloxone hydrochloride is 0.4 to 2 mg. (2) If respiratory function is not adequately offset or improved, intravenous doses may be repeated every 2 to 3 minutes.
Precautions
When opening the injection vial, glass fragments may become mixed, so extreme caution must be taken to prevent any glass contamination during use. This is particularly important when administering to children or the elderly. This medication should not be used in patients who are allergic to this drug or its components, those taking other central nervous system depressants, or individuals who are already experiencing respiratory depression. Patients with high blood pressure or heart diseases, as well as those with kidney or liver problems, should exercise increased caution when using this medication. Side effects such as elevated blood pressure, rapid heartbeat, nausea or vomiting, liver function abnormalities, sweating, and seizures may occur after using this medication. Overdose can lead to sudden pain or an excitatory state, so caution is advised. After administering this medication, preparation must be made to maintain the airway and provide artificial respiration or cardiac massage, and thorough monitoring for changes in blood pressure or pulmonary edema symptoms is essential. The effect of narcotic analgesics may be prolonged due to this medication, potentially leading to a reappearance of respiratory depression; thus, patients should be monitored continuously and re-dosing should be performed as necessary. Using this drug in patients with narcotic dependence or their infants can precipitate severe withdrawal symptoms and should be done with caution. The safety of this medication has not been established for pregnant women or those who may become pregnant; it should only be used when the benefits of treatment outweigh the risks. For breastfeeding women, it is not clear whether this drug is secreted in breast milk, but it is advisable to avoid use if possible, and to discontinue breastfeeding if it is deemed necessary.
Side effects
Seizures, cardiac arrest, pulmonary edema